Intravital microscopy: An innovative approach to track real-time muscle integrity and pathology in Pompe disease

References

[1] Jones HN, Hobson-Webb LD, Kuchibhatla M, et al. Tongue weakness and atrophy differentiates late-onset Pompe disease from other forms of acquired/hereditary myopathy. Mol Genet Metab. 2021;133(3):261-268.

[2] Dubrovsky A, Corderi J, Lin M, Kishnani PS, Jones HN. Expanding the phenotype of late-onset Pompe disease: tongue weakness: a new clinical observation. Muscle Nerve. 2011;44:897-901.

[3] Jacquemin G, Benavente-Diaz M, Djaber S, et al>. Longitudinal high-resolution imaging through a flexible intravital imaging window. Sci Adv. 2021;7(25):eabg7663.

[4] Buttigieg E, Scheller A, El Waly B, Kirchhoff F, Debarbieux F. Contribution of intravital neuroimaging to study animal models of multiple sclerosis. Neurotherapeutics. 2023;20:22-38.

[5] Mercier L, Böhm J, Fekonja N, et al. In vivo imaging of skeletal muscle in mice highlights muscle defects in a model of myotubular myopathy. Intravital. 2016;5(1):e1168553.

[6] Meena NK, Ng Y, Randazzo D, Weigert R, Puertollano R, Raben N. Intravital imaging of muscle damage and response to therapy in a model of Pompe disease. Clin Transl Med. 2024;14(3):e1561.

RIGHTS & PERMISSIONS

2024 2024 The Author(s). Clinical and Translational Discovery published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.